Prognostic value of the combined use of transient elastography and fibrotest in patients with chronic hepatitis B

Liver International

Volumn 35, Issue 2, 2015, Pages 455-462

  Park, Mi Sung ^a   Kim, Seung Up ^a,b   Kim, Beom Kyung ^a,b   Park, Jun Yong ^a,b   Kim, Do Young ^a,b   Ahn, Sang Hoon ^a,b,c   Shin, Seung Hwan ^a   Kang, Wonseok ^a,b   Moon, Chansoo ^a   Han, Kwang Hyub ^a,b,c  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

^c Brain Korea 21 Project for Medical Science   (South Korea)

Author keywords

Chronic hepatitis B; Fibrotest; Liver related event; Prognostic value; Transient elastography

Indexed keywords

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIGESTIVE TRACT PARAMETERS; ELASTOGRAPHY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER FUNCTION TEST KIT; LIVER STIFFNESS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; UNIVARIATE ANALYSIS; AREA UNDER THE CURVE; BIOPSY; CARCINOMA, HEPATOCELLULAR; CLINICAL TRIAL; COMPLICATION; DISEASE COURSE; LIVER; LIVER FAILURE; LIVER NEOPLASMS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL;

AREA UNDER CURVE; BIOPSY; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; ELASTICITY IMAGING TECHNIQUES; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER FAILURE; LIVER NEOPLASMS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; ROC CURVE;

EID: 84921537932     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12678     Document Type: Article

References (31)

1. Jang JW. Current status of liver diseases in Korea: liver cirrhosis. Korean J Hepatol 2009; 15(Suppl. 6): S40-9.
2. Lok AS. Hepatitis B: liver fibrosis and hepatocellular carcinoma. Gastroenterol Clin Biol 2009; 33: 911-5.
3. Kim BK, Fung J, Yuen MF, Kim SU. Clinical application of liver stiffness measurement using transient elastography in chronic liver disease from longitudinal perspectives. World J Gastroenterol 2013; 19: 1890-900.
4. Pungpapong S, Kim WR, Poterucha JJ. Natural history of hepatitis B virus infection: an update for clinicians. Mayo Clin Proc 2007; 82: 967-75.
5. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD. Liver biopsy. Hepatology 2009; 49: 1017-44.
6. Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495-500.
7. Jin SY. Role of liver biopsy in the assessment of hepatic fibrosis-its utility and limitations. Korean J Hepatol 2007; 13: 138-45.
8. Bruguera M, Abraldes JG. Common problems in the diagnosis and treatment of Wilson's disease. Gastroenterol Hepatol 2013; 36: 316-25.
9. Castera L, Pinzani M. Non-invasive assessment of liver fibrosis: are we ready? Lancet 2010; 375: 1419-20.
10. Kim SU, Jang HW, Cheong JY, et al. The usefulness of liver stiffness measurement using FibroScan in chronic hepatitis C in South Korea: a multicenter, prospective study. J Gastroenterol Hepatol 2011; 26: 171-8.
11. Lupsor M, Badea R, Stefanescu H, et al. Performance of a new elastographic method (ARFI technology) compared to unidimensional transient elastography in the noninvasive assessment of chronic hepatitis C Preliminary results. J Gastrointestin Liver Dis 2009; 18: 303-10.
12. Shaheen AA, Wan AF, Myers RP. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 2007; 102: 2589-600.
13. Raftopoulos SC, George J, Bourliere M, et al. Comparison of noninvasive models of fibrosis in chronic hepatitis B. Hepatol Int 2012; 6: 457-67.
14. Vergniol J, Foucher J, Terrebonne E, et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology 2011; 140: 1970-9, e1971-1973.
15. Morra R, Lebray P, Ingiliz P, et al. FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C. Hepatology 2008; 47: 353-4.
16. Jung KS, Kim SU, Ahn SH, et al. Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan). Hepatology 2011; 53: 885-94.
17. Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343-50.
18. Kim BK, Kim SU, Kim HS, et al. Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B. PLoS ONE 2012; 7: e35825.
19. KASL Clinical Practice Guidelines. Management of chronic hepatitis B. Clin Mol Hepatol 2012; 18: 109-62.
20. Kim SU, Ahn SH, Park JY, et al. Liver stiffness measurement in combination with noninvasive markers for the improved diagnosis of B-viral liver cirrhosis. J Clin Gastroenterol 2009; 43: 267-71.
21. Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. J Hepatol 2008; 48: 835-47.
22. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995; 19: 1409-17.
23. Heagerty PJ, Lumley T, Pepe MS. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000; 56: 337-44.
24. Lucidarme D, Foucher J, Le Bali B, et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009; 49: 1083-9.
25. Regev A, Berho M, Jeffers LJ, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614-8.
26. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut 2006; 55: 403-8.
27. Marcellin P, Ziol M, Bedossa P, et al. Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B. Liver Int 2009; 29: 242-7.
28. Poynard T, Ngo Y, Munteanu M, Thabut D, Ratziu V. Noninvasive markers of hepatic fibrosis in chronic hepatitis B. Curr Hepat Rep 2011; 10: 87-97.
29. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-93.
30. Masuzaki R, Tateishi R, Yoshida H, et al. Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography. Hepatology 2009; 49: 1954-1961.
31. Park MS, Kim BK, Cheong JY, et al. Discordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B. PLoS ONE 2013; 8: e55759.